First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany-Reference-Cited by-同舟云学术

First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany

Published:2021-08 Issue:8 Volume:40 Page:850-855
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Bernhardt Alexander M.,Potapov Evgenij,Schibilsky David,Ruhparwar Arjang,Tschöpe Carsten,Spillmann Frank,Benk Christoph,Schmack Bastian,Schmitto Jan D.,Napp L. Christian,Mayer-Wingert Nadja,Doll Nicolas,Reichenspurner Hermann,Schulte-Eistrup Sebastian

Funder

Abbott Laboratories

Pfizer

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference20 articles.

1. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière;Mastroianni;Eur Hear journal Acute Cardiovasc care,2017

2. Effectiveness and safety of the impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device;Lima;Am J Cardiol,2016

3. Impella 5.0 as a second-line mechanical circulatory support strategy after extracorporeal life support;Schibilsky;Artif Organs,2016

4. Impella 5.0 support in INTERMACS II cardiogenic shock patients using right and left axillary artery access;Schibilsky;Artif Organs,2015

5. Outcomes of impella 5.0 in cardiogenic shock;Batsides;Innov Technol Tech Cardiothorac Vasc Surg,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impella 5.5: A Systematic Review of the Current Literature;Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery;2024-09-12

2. Bridge to Life: Current Landscape of Temporary Mechanical Circulatory Support in Heart-Failure-Related Cardiogenic Shock;Journal of Clinical Medicine;2024-07-14

3. Prolonged Impella 5.0/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center;Frontiers in Cardiovascular Medicine;2024-07-02

4. Umbrella review of risk factors for inflammatory bowel disease: a study protocol;BMJ Open;2024-06

5. Impella versus VA-ECMO for the treatment of patients with cardiogenic shock: the Impella Network Project – observational study protocol for cost-effectiveness and budget impact analyses;BMJ Open;2024-06